Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-20 Purchase | 2021-12-22 6:21 pm | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 63,850 | $10.18 | $649,993 | 4,056,907 (Indirect) | View |
| 2021-03-23 Purchase | 2021-03-25 6:05 pm | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 882,351 | $17 | $14,999,967 | 882,351 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-08 Option Award | 2023-06-09 4:16 pm | N/A 2033-06-07 | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 5:01 pm | N/A 2032-06-12 | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 44,843 | $0 | 44,843 (Direct) | View |
| 2021-03-23 Conversion | 2021-03-25 6:05 pm | N/A N/A | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 3,110,706 | $0 | 882,351 (Indirect) | View |
Ownership | 2021-03-18 9:18 pm | N/A N/A | Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director | 0 | $0 | 3,110,706 (Indirect) | View |